Jim Woody

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

Talima Therapeutics, Inc. operated as a drug delivery company. It had developed a micro implant delivery technology for the localized application of small molecule drugs. The firm’s product was in phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the toenails. The company was founded in 2004 and was headquartered in San Carlos, CA.

Femta Pharmaceuticals, Inc. develops antibody therapeutics. The company was founded in June 2008 and is headquartered in San Diego, CA.

Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA.

HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA.

IntegenX, Inc. develops rapid human DNA identification technology, next-gen sequencing library preparation, and DNA/RNA ambient temperature stability and storage products. The firm platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce products for DNA-based human identity testing and forensics and biodefense applications. The company was founded by Stevan Jovanovich, Dennis W. Harris, Richard A. Mathies in 2003 and is headquartered in Pleasanton, CA.

Part of Roche Holding AG, Roche Bioscience is a private company that discovers and develops prescription drugs. The company is based in Palo Alto, CA.

Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA.

Pharmix Corp. develops novel pharmaceuticals. The company designs novel compounds that avoid issues that impact health candidate attrition. Pharmix was founded in 2000 and is headquartered in Brisbane, CA.

PerceptiMed, Inc. develops and markets a medical device for eliminating medical errors in pharmacies. The firm's products include IdentRx, IdentRx telepharmacy, MedPass, and ScripClip. Its technology identifies the composition of individual pills in real-time, checks each and every pill against the doctor's prescription, and ensures delivery to the patient. The company was founded by Alan Jacobs and Jennifer L. Jacobson is headquartered in Mountain View, CA.

Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA.

Lucile Salter Packard Children''s Hospital at Stanford engages in the provision of hospital services. It focuses on the obstetric and pediatric areas: brain and behavior, cancer, heart, pregnancy and newborn, pulmonary, and transplant. Its practices and services include anesthesia, cancer and blood diseases, cardiology, cardiovascular intensive care, dialysis, labor and delivery, neonatology, perinatal diagnostic center, pharmacy services, pulmonary function laboratory, radiology, rehabilitation services, social services, speech and language, and before and after surgical care. The company was founded in 1991 and is headquartered in Palo Alto, CA.

KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in New York, NY.

180 Life Sciences Corp. engages in manufacture of pharmaceutical products. The company is headquartered in New York.

Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA.

Avidia, Inc. developed pharmaceutical products. The company developed a novel, proprietary class of small therapeutic proteins. The company was headquartered in Mountain View, CA.

Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021.

MARABio Systems, Inc. manufactures testing products for autism. The company is based in Menlo Park, CA. The company was founded by Judy van de Water. Michael S. Paul has been the CEO of the company since 2023.